153 related articles for article (PubMed ID: 30191636)
1. Inhibition of kinesin family member 20B sensitizes hepatocellular carcinoma cell to microtubule-targeting agents by blocking cytokinesis.
Liu X; Li Y; Zhang X; Liu XY; Peng A; Chen Y; Meng L; Chen H; Zhang Y; Miao X; Zheng L; Huang K
Cancer Sci; 2018 Nov; 109(11):3450-3460. PubMed ID: 30191636
[TBL] [Abstract][Full Text] [Related]
2. Reducing protein regulator of cytokinesis 1 as a prospective therapy for hepatocellular carcinoma.
Liu X; Li Y; Meng L; Liu XY; Peng A; Chen Y; Liu C; Chen H; Sun S; Miao X; Zhang Y; Zheng L; Huang K
Cell Death Dis; 2018 May; 9(5):534. PubMed ID: 29748662
[TBL] [Abstract][Full Text] [Related]
3. Kinesin-6 KIF20B is required for efficient cytokinetic furrowing and timely abscission in human cells.
Janisch KM; McNeely KC; Dardick JM; Lim SH; Dwyer ND
Mol Biol Cell; 2018 Jan; 29(2):166-179. PubMed ID: 29167382
[TBL] [Abstract][Full Text] [Related]
4. Molecular chaperone CCT3 supports proper mitotic progression and cell proliferation in hepatocellular carcinoma cells.
Zhang Y; Wang Y; Wei Y; Wu J; Zhang P; Shen S; Saiyin H; Wumaier R; Yang X; Wang C; Yu L
Cancer Lett; 2016 Mar; 372(1):101-9. PubMed ID: 26739059
[TBL] [Abstract][Full Text] [Related]
5. Kinesin family member 20B regulates tongue cancer progression by promoting cell proliferation.
Li ZY; Wang ZX; Li CC
Mol Med Rep; 2019 Mar; 19(3):2202-2210. PubMed ID: 30664160
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Kinesin spindle protein inhibits proliferation, induces apoptosis and increases chemosensitivity in hepatocellular carcinoma cells.
Doan CC; Doan NT; Nguyen QH; Nguyen MH; Do MS; Le VD
Iran Biomed J; 2015; 19(1):1-16. PubMed ID: 25605484
[TBL] [Abstract][Full Text] [Related]
7. KIF20B promotes the progression of clear cell renal cell carcinoma by stimulating cell proliferation.
Li G; Xie ZK; Zhu DS; Guo T; Cai QL; Wang Y
J Cell Physiol; 2019 Sep; 234(9):16517-16525. PubMed ID: 30805928
[TBL] [Abstract][Full Text] [Related]
8. MPHOSPH1: a potential therapeutic target for hepatocellular carcinoma.
Liu X; Zhou Y; Liu X; Peng A; Gong H; Huang L; Ji K; Petersen RB; Zheng L; Huang K
Cancer Res; 2014 Nov; 74(22):6623-34. PubMed ID: 25269478
[TBL] [Abstract][Full Text] [Related]
9. Pseudopod-associated protein KIF20B promotes Gli1-induced epithelial-mesenchymal transition modulated by pseudopodial actin dynamic in human colorectal cancer.
Lin WF; Lin XL; Fu SW; Yang L; Tang CT; Gao YJ; Chen HY; Ge ZZ
Mol Carcinog; 2018 Jul; 57(7):911-925. PubMed ID: 29573464
[TBL] [Abstract][Full Text] [Related]
10. Small interfering RNA targeting alpha7 nicotinic acetylcholine receptor sensitizes hepatocellular carcinoma cells to sorafenib.
Hajiasgharzadeh K; Somi MH; Mansoori B; Khaze Shahgoli V; Derakhshani A; Mokhtarzadeh A; Shanehbandi D; Baradaran B
Life Sci; 2020 Mar; 244():117332. PubMed ID: 31962133
[TBL] [Abstract][Full Text] [Related]
11. 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming.
Chen H; Wu D; Bao L; Yin T; Lei D; Yu J; Tong X
Biomed Pharmacother; 2019 Mar; 111():1353-1358. PubMed ID: 30841449
[TBL] [Abstract][Full Text] [Related]
12. Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism.
Kim YS; Lee YM; Oh TI; Shin DH; Kim GH; Kan SY; Kang H; Kim JH; Kim BM; Yim WJ; Lim JH
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321984
[TBL] [Abstract][Full Text] [Related]
13. A Monoclonal Antibody to M-Phase Phosphoprotein 1/Kinesin-Like Protein KIF20B.
Fritzler MJ; Brown RD; Zhang M
Monoclon Antib Immunodiagn Immunother; 2019 Aug; 38(4):162-170. PubMed ID: 31260385
[TBL] [Abstract][Full Text] [Related]
14. USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt.
Zhang J; Luo N; Tian Y; Li J; Yang X; Yin H; Xiao C; Sheng J; Li Y; Tang B; Li R
Oncotarget; 2017 Apr; 8(15):24728-24740. PubMed ID: 28445968
[TBL] [Abstract][Full Text] [Related]
15. Tivantinib induces G2/M arrest and apoptosis by disrupting tubulin polymerization in hepatocellular carcinoma.
Xiang Q; Zhen Z; Deng DY; Wang J; Chen Y; Li J; Zhang Y; Wang F; Chen N; Chen H; Chen Y
J Exp Clin Cancer Res; 2015 Oct; 34():118. PubMed ID: 26458953
[TBL] [Abstract][Full Text] [Related]
16. Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer.
Mbugua RW; Takano A; Tsevegjav B; Yokose T; Yamashita T; Miyagi Y; Daigo Y
Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38426627
[TBL] [Abstract][Full Text] [Related]
17. PMPCB Silencing Sensitizes HCC Tumor Cells to Sorafenib Therapy.
Zheng JF; He S; Zeng Z; Gu X; Cai L; Qi G
Mol Ther; 2019 Oct; 27(10):1784-1795. PubMed ID: 31337603
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression.
Kwon S; Jeon JS; Ahn C; Sung JS; Choi I
Biochem Biophys Res Commun; 2016 Oct; 479(1):74-9. PubMed ID: 27616194
[TBL] [Abstract][Full Text] [Related]
19. Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma.
Yoo JJ; Yu SJ; Na J; Kim K; Cho YY; Lee YB; Cho EJ; Lee JH; Kim YJ; Youn H; Yoon JH
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875800
[TBL] [Abstract][Full Text] [Related]
20. Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulin.
Gan PP; McCarroll JA; Po'uha ST; Kamath K; Jordan MA; Kavallaris M
Mol Cancer Ther; 2010 May; 9(5):1339-48. PubMed ID: 20442307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
